PHY906: Clinical Trials

3 trials of PHY906, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 23Completed 2, Terminated 1

Follow PHY906: new trials by email Literature Review of PHY906 trials Research Report on PHY906

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
Capecitabine, PHY906 - Pancreatic Cancer
Phase 1 / Phase 2CompletedYale University252006-12-012015-03-27
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
PHY906, capecitabine - Hepatocellular Carcinoma, Liver Cancer
Phase 1 / Phase 2CompletedPhytoCeutica312003-10-012007-03-28
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
PHY906 - Colorectal Neoplasms, Diarrhea
Phase 1 / Phase 2TerminatedPhytoCeutica302002-02-012005-06-24

Conditions studied

Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Diarrhea (1)  ·  Liver Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Sponsors

PhytoCeutica (2)  ·  Yale University (1)

Countries

United States (3)  ·  Taiwan (1)

Top investigators

Howard Hochester, MD (1)  ·  Wayne D Brenckman, Jr., MD (1)